| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $737.9M | +40.2% |
| R&D Expense | $93.9M | +9.4% |
| SG&A Expense | $139.8M | +12.3% |
| Pre-tax Income | -$160.9M | +21.1% |
| Income Tax | $4.6M | +370.6% |
| Net Income | -$165.5M | +18.2% |
| EPS (Basic) | -$2.24 | +21.4% |
| EPS (Diluted) | -$2.24 | +21.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $385.0M | +2.4% |
| Short-term Investments | $14.1M | -48.7% |
| Total Assets | $1.93B | +4.1% |
| Total Liabilities | $1.39B | +10.9% |
| Stockholders' Equity | $533.6M | -10.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.5M | -44.7% |
| Capital Expenditures | $9.4M | +0.0% |
| Investing Cash Flow | -$89.1M | -319.5% |
| Financing Cash Flow | $106.6M | +21.6% |
| Free Cash Flow | -$25.9M | -24.5% |